Subscribe
digital-storm-shutterstock-com-f1-2
13 September 2016Copyright

Formula One takeover: a rocky road for IP?

Following the announcement that US  mass media company Liberty Media has agreed to buy Formula One (F1) for $8 billion, lawyers tell WIPR how trademarks, brands and licences could be affected.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Trademarks
Formula One on collision course with 3M over trademark application
14 June 2018   Technology company 3M has opposed a trademark that was applied for by racing organisation Formula One, after 3M claimed the mark was too similar to its previously registered trademark.


Editor's picks

Four firms reach highest tier in WIPR’s 2025 Global Trade Secrets Rankings
Trade secrets
Four firms reach highest tier in WIPR’s 2025 Global Trade Secrets Rankings
18 August 2025

Editor's picks

Trade secrets
Four firms reach highest tier in WIPR’s 2025 Global Trade Secrets Rankings
18 August 2025
Future of IP
Trump’s tariffs: Will your TMs survive the trade wars?
13 August 2025
Patents
Why Trump’s revenue-raising patent plan is rife with problems
12 August 2025
Patents
In focus: EPO's landmark G1/25 referral and what it could mean
5 August 2025
Trademarks
The $53m cutback to $1: Lessons from MGA Entertainment v OMG Girlz
4 August 2025
Trade secrets
Propel Fuels nets $883m in trade secrets dispute
1 August 2025

More articles

Artist challenges US Copyright Office decision over image that used AI
An update on patenting in Ukraine, Russia and Eurasia
China filings push rise in Ireland patent applications
Why the Caribbean cannabis economy is ripe for IP protection
A bright future for Brazil
Anthropic avoids damages risk in deal with authors over AI training
Five key 2025 trademark judgments from the EU general court
The right formula: Minimising the cost of chemical and pharma patents